Secondary Prevention for Alzheimer Disease: Timing, Selection, and Endpoint of Clinical Trials

L. Vermunt

    Research output: PhD ThesisPhD Thesis - Research VU, graduation VU

    Original languageEnglish
    Awarding Institution
    • Vrije Universiteit Amsterdam
    • Scheltens, P., Supervisor, External person
    • Visser, P.J., Co-supervisor, External person
    • Tijms, B.M., Co-supervisor, External person
    Award date13 Mar 2020
    Publication statusPublished - 2020


    • Alzheimer disease
    • trial design
    • preclinical
    • prodromal stages
    • disease modelling
    • autosomal dominant
    • structural covariance networks
    • imaging
    • csf
    • biomarkers

    Cite this